Nicht aus der Schweiz? Besuchen Sie lehmanns.de
Cardio-Oncology -

Cardio-Oncology

The Clinical Overlap of Cancer and Heart Disease
Buch | Softcover
XV, 319 Seiten
2018 | 1. Softcover reprint of the original 1st ed. 2017
Springer International Publishing (Verlag)
978-3-319-82737-7 (ISBN)
CHF 134,80 inkl. MwSt
  • Versand in 10-15 Tagen
  • Versandkostenfrei
  • Auch auf Rechnung
  • Artikel merken

Co-edited and written by an interdisciplinary team of experts in oncology and cardiology, this book is a clinically useful resource on these overlapping topics:

- Cardiac complications in patients receiving cancer therapy

- The treatment of cancer in patients with cardiovascular disease

- The treatment of cardiovascular disease in patients with cancer

When relevant to medical practice, epidemiology and basic science are also included in the discussion and each chapter is written by an oncologist and a cardiologist. Additionally, the chapters follow a similar format to make the book truly interdisciplinary, user-friendly, and clinically applicable to specialists and non-specialists who care for patients with both cancer and cardiovascular disease.


Gretchen Genevieve Kimmick, MD, MS Associate Professor of Medicine with Tenure Division of Medical Oncology Department of Internal Medicine Duke University School of Medicine Durham, NC USA Dawn L. Hershman, MD, MS Associate Professor of Medicine and Epidemiology with Tenure Columbia University College of Physicians & Surgeons; Leader, Breast Cancer Program, and Associate Director, Program Development Herbert Irving Comprehensive Cancer Center Columbia University Medical Center; Assistant Attending Physician Presbyterian Hospital New York, NY USA Douglas Brian Sawyer, MD, PhD Professor of Medicine and Pharmacology Cardiovascular Division, Department of Medicine Vanderbilt University School of Medicine; Physician, Heart Failure Program, Vanderbilt University Medical Center; Consulting Cardiologist, Nashville Veterans Administration Hospital; Consulting Cardiologist, Meharry Medical Center, Nashville General; Former Physician-in-Chief (2008-2013), Vanderbilt Heart and Vascular Institute Nashville, TN USA Daniel J. Lenihan, M.D. Professor Director of Clinical Research Program Director, Fellowship in Heart Failure/Transplantation Division of Cardiovascular Medicine Department of Medicine, Vanderbilt University, Nashville, TN USA

Chapter 1 Epidemiology of Cardio-Oncology.- Chapter 2 Cardiotoxicity of Anticancer Therapies.- Chapter 3 Screening and Monitoring for Cardiotoxicity during Cancer Treatment.- Chapter 4 Management of Chemotherapy-Associated Cardiomyopathy.- Chapter 5 Treatment of hypertension in patients receiving cancer therapy.- Chapter 6 Pre-operative and pre-transplant cardiac evaluation in the cancer patient.- Chapter 7 Radiation Therapy and Cardiotoxicity.- Chapter 8 Management of patients with coronary disease and cancer: Interactions between cancer, cancer treatment and ischemia.- Chapter 9 Vascular Complications of Cancer and Cancer Therapy.- Chapter 10 Breast Cancer Cardio-Oncology.- Chapter 11 Cardiac Toxic Chemotherapy and Cancer Survivorship.- Chapter 12 Geriatric Cardio-Oncology.- Chapter 13 Future Clinical and Professional Directions in Cardio-Oncology.

Erscheint lt. Verlag 18.7.2018
Zusatzinfo XV, 319 p. 55 illus., 49 illus. in color.
Verlagsort Cham
Sprache englisch
Maße 155 x 235 mm
Gewicht 694 g
Themenwelt Medizin / Pharmazie Gesundheitswesen
Medizinische Fachgebiete Innere Medizin Kardiologie / Angiologie
Medizin / Pharmazie Medizinische Fachgebiete Onkologie
Schlagworte Cancer • Cardio-Oncology • Geriatric • Heart disease • Survivorship • treatment complications
ISBN-10 3-319-82737-5 / 3319827375
ISBN-13 978-3-319-82737-7 / 9783319827377
Zustand Neuware
Haben Sie eine Frage zum Produkt?
Mehr entdecken
aus dem Bereich
in Fällen, Fragen und Antworten

von Christoph Spes; Volker Klauss; Sibylle Tönjes

Buch | Softcover (2024)
Urban & Fischer in Elsevier (Verlag)
CHF 124,60

von Julia Christ

Buch | Softcover (2022)
Urban & Fischer in Elsevier (Verlag)
CHF 37,80